On Monday, Jubilant Pharma announced that it has developed a novel oral formulation of Remdesivir, which, the company said, is likely to ease the capacity...
A UK trial of potential Covid-19 treatments has started to enroll patients in other countries in the hope of speeding up results, Oxford University said on Thursday....